BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Equity-to-Asset : 0.70 (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Total Stockholders Equity for the quarter that ended in Feb. 2024 was $132.68 Mil. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Total Assets for the quarter that ended in Feb. 2024 was $188.68 Mil. Therefore, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity to Asset Ratio for the quarter that ended in Feb. 2024 was 0.70.

The historical rank and industry rank for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset or its related term are showing as below:

DCF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.64 Med: 0.68 Max: 0.7
Current: 0.7

During the past 6 years, the highest Equity to Asset Ratio of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund was 0.70. The lowest was 0.64. And the median was 0.68.

DCF's Equity-to-Asset is ranked worse than
63.22% of 1729 companies
in the Asset Management industry
Industry Median: 0.83 vs DCF: 0.70

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Equity-to-Asset Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Equity-to-Asset Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Equity-to-Asset

Get a 7-Day Free Trial

0.68

0.69

0.65

0.64

0.70

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Equity-to-Asset	Get a 7-Day Free Trial						0.68	0.64	0.65	0.70	0.70

Competitive Comparison of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset

For the Asset Management subindustry, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset falls into.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity to Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Equity to Asset (A: Aug. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	123.539	/	176.51
	=	0.70

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	132.683	/	188.676
	=	0.70

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund (NYSE:DCF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o BNY Mellon Investment Adviser, Inc., 240 Greenwich Street, New York, NY, USA, 10286

Website

https://www.bnymellonim.com

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.

Executives

Bushra Mannan	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang	other: Dir. of Invest. Oversight (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak	officer: President	200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella	officer: VP	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein	officer: VP	240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy	officer: VP; Investment Adviser	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel	other: Head of Finance of Sub-Adviser	200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc	other: Sub-Adviser	200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson	other: Portfolio Mgr of Sub-Adviser	C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166